The DNA data of millions of people who used 23andMe’s services won’t be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth of genetic data, to a nonprofit led by co-founder Anne Wojcicki.
23andMe
Posted inNPR
23andMe is on the brink. What happens to all its DNA data?
The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the spotlight on the genetic data it has on 15 million people.
